An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
about
Aptamers as therapeutics in cardiovascular diseases.Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins.Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.
P2860
An anti-von Willebrand factor aptamer reduces platelet adhesion among patients receiving aspirin and clopidogrel in an ex vivo shear-induced arterial thrombosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
An anti-von Willebrand factor ...... r-induced arterial thrombosis.
@en
type
label
An anti-von Willebrand factor ...... r-induced arterial thrombosis.
@en
prefLabel
An anti-von Willebrand factor ...... r-induced arterial thrombosis.
@en
P2093
P2860
P356
P1476
An anti-von Willebrand factor ...... r-induced arterial thrombosis.
@en
P2093
Dabit Arzamendi
Firas Dandachli
Gregory Ducrocq
James C Gilbert
Jean-François Tanguay
Jean-François Théorêt
Robert G Schaub
Walid Mourad
Yahye Merhi
P2860
P356
10.1177/1076029610384114
P577
2010-11-15T00:00:00Z